Thursday, March 22, 2012 – 12-1 pm EDT

After registration, you will receive an e-mail confirmation with instructions for joining the webinar. The handout will be available at least 24 hours before the webinar.

Accreditation for Pharmacists
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The activity provides 1 hour (0.1 CEU) of continuing pharmacy education credit (activity # 204-000-12-404-L01P).

Methods and Format
This is a live web-based activity consisting of audio, presentation slides, and an activity evaluation tool. Participants must participate in the entire presentation and complete the course evaluation to receive continuing pharmacy education credit. Participants may print their official statements of continuing pharmacy education credit immediately following the activity. This activity is provided free of charge. Click here for full CE processing instructions.

Target Audience
This continuing pharmacy education activity was planned to meet the needs of pharmacists in a variety of practice settings, including large and small health systems, outpatient clinics, managed-care organizations, long-term care facilities, and academia. This activity is particularly beneficial for pharmacists, clinical specialists, managers, leaders, and educators who are interested in current strategies for the management of dyslipidemia.

Webinar Overview
This activity will focus on evidence that has been published since the release of the National Cholesterol Education Panel (NCEP) Adult Treatment Panel III (ATPIII) guidelines. Based on these data, faculty will predict changes that might be seen in the newest version of the NCEP guidelines (the ATP IV), which are due to be released in 2012.

The content for this live webinar is based on questions raised by participants in a recent educational symposium on this topic. Time for questions and answers from the webinar audience will be provided at the end of the presentation.

Learning Objectives
At the conclusion of this knowledge-based continuing pharmacy education activity, participants should be able to

• Describe at least two evidence-based recommendations for dyslipidemia treatment that are different than what is currently recommended in the NCEP ATP III.
• Explain the proven patient demonstrated benefits of specific drug therapy options for the treatment of dyslipidemia.

Faculty
Joseph Saseen, Pharm.D., FASHP, FCCP, BCPS
Professor, Clinical Pharmacy and Family Medicine
Vice Chair, Department of Clinical Pharmacy
University of Colorado Anschutz Medical Center
Aurora, Colorado

View Webinar Frequently Asked Questions Page